- letzte 200 News
- Archiv
| Zeit | Aktuelle Nachrichten | Rating | Leser | ||
|---|---|---|---|---|---|
| 10.03. | GlobalData - Connected intelligence platform | 378 | GlobalData's results were as flagged, with the first year of its transformation plan setting the foundations for management's goal of £500m of annualised revenue by end 2026. To get there it has to... ► Artikel lesen | ||
| 10.03. | Cantargia (OMX: CANTA) breast cancer study fully recruited | 282 | Cantargia has announced that it has completed recruiting patients (n=102) for the randomised Phase II TRIFOUR trial, which is evaluating nadunolimab in combination with platinum-based chemotherapy,... ► Artikel lesen | ||
| 10.03. | Datatec - A closer look at Logicalis International | 313 | Logicalis International is the second largest business within the Datatec group, generating a third of adjusted EBITDA in FY24. With international presence and strong vendor relationships, the business... ► Artikel lesen | ||
| 10.03. | Canyon Resources - Strategic investment in Camrail | 298 | Canyon Resources has announced that Camalco, its wholly owned in-country subsidiary, has entered into two agreements to acquire a 9.1% combined interest in Camrail, Cameroon's rail operator. The transaction... ► Artikel lesen | ||
| 10.03. | Melrose Industries - The horizon remains positive | 428 | Melrose continues to build on its track record of delivering to expectations. Indeed the Engines division has achieved FY25 target returns a year early. This provides confidence in management's new... ► Artikel lesen | ||
| 10.03. | MCB Group - Financing the growth of African economies | 231 | MCB Group (MCB) has reported solid H1 results, with 25.7% y-o-y EPS growth and an annualised return on equity of 18.4% (H124: 16.6%), continuing its strong double-digit earnings growth, while maintaining... ► Artikel lesen | ||
| 10.03. | AVAX - Significant year-on-year growth expected | 234 | In this note, we show revisions to our forecasts and our updated valuation of AVAX ahead of the company's FY24 results (expected April 2025). AVAX's H124 revenues and EBITDA were up 50.4% and 97.5%... ► Artikel lesen | ||
| 10.03. | NWF (LON: NWF) acquires Northern Energy Oil | 275 | NWF has agreed to purchase 42m litre fuel distributor Northern Energy Oil for up to £8.3m, depending on certain post-completion conditions. Northern Energy Oil operates from five sites in North Yorkshire... ► Artikel lesen | ||
| 07.03. | OSE Immunotherapeutics - KOL event highlights lusvertikimab's potential | 316 | OSE Immunotherapeutics and Edison held a key opinion leader (KOL) event on 5 March 2025, providing up-to-date insights into OSE's lead immuno-inflammation candidate, lusvertikimab, following the European... ► Artikel lesen | ||
| 07.03. | Severfield - Full year trading update disappoints | 318 | Trading conditions have not improved as hoped for in the second half of the current financial year, which has resulted in a reduction in Severfield's expected outcome for FY25. This weakness is reflected... ► Artikel lesen | ||
| 07.03. | Patria Private Equity Trust - An attractive route to the PE mid-market | 322 | Patria Private Equity Trust (formerly known as abrdn Private Equity Opportunities Trust) allows investors to gain exposure to a gradually rebounding private equity (PE) market via a trust active in... ► Artikel lesen | ||
| 07.03. | Informa - FY25-28 plan for leveraging B2B platform | 356 | Informa used its FY24 results presentation to highlight its strategy for the next three years. This is centred on leveraging the One Informa platform, focused on B2B, through its market-leading brands... ► Artikel lesen | ||
| 06.03. | Games Workshop Group - Momentum continued into Q325 | 517 | Games Workshop Group's (GAW's) trading update states core and licensing revenue in January and February 2025 have been better than expected, continuing the momentum in Q325 that was reported at the... ► Artikel lesen | ||
| 06.03. | Apax Global Alpha - Seeking a fresh start | 404 | Apax Global Alpha's (AGA's) investment advisor (Apax) and board have been proactively addressing the factors behind AGA's subdued performance in recent years (including a 0.8% NAV total return (TR)... ► Artikel lesen | ||
| 06.03. | Lancashire Holdings - Substantial shareholder distributions | 346 | Lancashire Holdings released its FY24 results on 6 March and declared another 25c/share special dividend on top of the 75c/share declared in November 2024. This brings combined special dividend declarations... ► Artikel lesen | ||
| 06.03. | Capita Group - AI driving transformation in 2025 | 416 | FY24 was a transformative year for Capita Group. With a new CEO and CFO, the company made good progress on its 'Better Capita' strategy. Capita is at the forefront of the significant opportunity arising... ► Artikel lesen | ||
| 06.03. | Greggs - Performing well in a challenging market | 314 | FY24 was a good year for Greggs as its long-term strategy to grow revenue, coupled with more favourable input cost inflation, provided better profit growth than in FY23. In common with many consumer... ► Artikel lesen | ||
| 05.03. | Team Internet Group - Rebasing for Google Adsense transition | 414 | We are re-initiating forecasts on Team Internet to reflect Verdane's decision not to make an offer for the business (removing Take Over Panel research restrictions) and the company's trading update... ► Artikel lesen | ||
| 05.03. | IRLAB Therapeutics (OMX: IRLAB-A) misses primary endpoint with pirepemat | 296 | IRLAB Therapeutics has announced top-line results from the Phase IIb REACT-PD study evaluating its second most clinically advanced asset, pirepemat, as a potential treatment for falls related to Parkinson's... ► Artikel lesen | ||
| 05.03. | Cantargia (OMX: CANTA) reports positive CAN10 update | 286 | Cantargia has reported encouraging pharmacokinetic data from the first cohort in the multiple ascending dose portion of the CAN10 study. Importantly, the data align with the single dose portion of the... ► Artikel lesen | ||
| 05.03. | Verve Group - Strong Q4 with good momentum into FY25 | 552 | Verve delivered a strong Q424, with organic net revenue growth of 24%, and resultant progress for the full year of 36% to €437m, clearly outstripping our modelled €420m. The group's focus on ID-less... ► Artikel lesen | ||
| 05.03. | Oryzon (BME: ORY) publishes results of vafidemstat in PMS | 307 | Oryzon Genomics has announced the publication of a study in Frontiers in Psychiatry, which explores the potential of vafidemstat in Phelan-McDermid Syndrome (PMS). PMS is a form of autism whereby agitation... ► Artikel lesen | ||
| 05.03. | SIG (LSE: SHI) - FY24 results in line; outlook H2 biased | 282 | SIG confirmed FY24 revenue of £2.6bn (FY23: £2.8bn) and operating profit of £25.1m (FY23: £53.1m), in line with January's FY24 trading update. Although full-year like-for-like revenue declined by 4%... ► Artikel lesen | ||
| 05.03. | Foxtons (LSE: FOXT) - FY24 results ahead of expectations; confident outlook | 329 | Foxtons' FY24 results were modestly ahead of guidance, with revenue up 11% to £163.9m and operating profit up 38% to £21.6m (FY23; £15.7m on a revised basis). Although Lettings and Financial Services... ► Artikel lesen | ||
| 05.03. | Freelancer Limited - Q424 results point to stronger FY25 | 319 | Freelancer reported FY24 results that confirmed that the core Freelancer marketplace saw improved customer acquisition and retention in Q424, providing positive momentum going into FY25. With a streamlined... ► Artikel lesen |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
